There is a need for effective and well-tolerated treatments that can be used in the early stages of dementia. Overall, the evidence suggests that taking a standardized, proprietary ginkgo extract may be an effective intervention for the primary and secondary prevention of cognitive impairment and mild to moderate dementia. To confirm the efficacy in patients with mild dementia, Riepe et al. conducted a meta-analysis.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
- InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
You May Also Like
- Sarcoidosis, echinococcosis & Co.
Suspected symptoms and differential diagnoses
- Cancer prevention
Constant dripping – alcohol and cancer
- Steatotic liver disease
GLP-1RA in MASH – what’s new?
- Chronic pruritus: “Tour d'horizon”
Focus on new anti-inflammatory therapeutic approaches
- Multiple sclerosis
Unexpected side effects when switching from natalizumab to a biosimilar
- "Patients W.A.I.T. Indicator"
Access to new drugs is becoming increasingly difficult
- Immunotherapy
Subcutaneously or intravenously?
- Work-related asthma